YU-CHUNG CHUANGChen S.-C.Mu J.-J.Lin H.-Y.Chang C.-H.WEI-SHIUNG YANGPO-REN HSUEH2021-07-022021-07-0220111080-6040https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930486610&doi=10.3201%2feid1712.110739&partnerID=40&md5=daa942c65d7b8a333e8743a798249f2ahttps://scholars.lib.ntu.edu.tw/handle/123456789/567626[SDGs]SDG3alanine aminotransferase; alkaline phosphatase; bacterial antigen; bacterium antibody; bilirubin; brucella antibody; brucella antigen; C reactive protein; ceftriaxone; cotrimoxazole; doxycycline; gallium; gentamicin; hemoglobin; nonsteroid antiinflammatory agent; procalcitonin; tigecycline; unclassified drug; adult; alanine aminotransferase blood level; alkaline phosphatase blood level; anorexia; antibiotic sensitivity; backache; bilirubin blood level; Brucella; brucellosis; case report; computer assisted tomography; dysuria; echography; epidural abscess; epigastric pain; female; fever; genetic polymorphism; human; letter; leukocyte count; low back pain; minimum inhibitory concentration; myalgia; nuclear magnetic resonance imaging; nucleotide sequence; osteomyelitis; outcome assessment; physical examination; serology; spleen infarction; splenomegaly; Taiwan; treatment duration; treatment response; virus hepatitisletter10.3201/eid1712.1107392-s2.0-84930486610